Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Provincial FDA Probes Drug Maker Over Herbal Injectable

This article was originally published in PharmAsia News

Executive Summary

A Chinese provincial FDA is investigating drug maker Xi'an Jiahui Pharmaceutical over its injectable herbal drug for chronic renal failure. The Shaanxi Province FDA said the company has voluntarily closed its facilities while the probe continues into chills and high fever reported in 23 patients given the drug at a hospital. Two batches of the drug came up positive in a pyrogen reaction test, but an initial investigation suggests the drug maker's production did not violate any laws and that technical problems may have been involved. The two batches were recalled. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts